NCT06659705 2026-04-15
INDIGO-FAPI
Institut Curie
Phase 2 Recruiting
Clinical Trials
10 trialsNCT07036978 2026-04-15
Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer
Chang Gung Memorial Hospital
Not yet recruiting
NCT07301229 2025-12-24
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer
Shanghai Henlius Biotech
Phase 2 Not yet recruiting
NCT06182072 2025-10-01
ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)
ProDa BioTech, LLC
Phase 1 Recruiting
NCT06481397 2025-07-02
OSCAR I STUDY - The ONCObind CTC Removal Study
ExThera Medical Corporation
Phase NA Completed
NCT04990609 2025-05-21
EUS-RFA PANCARDINAL-1 Trial
The University of Texas Health Science Center, Houston
Phase 2 Recruiting
NCT06967662 2025-05-16
INTRACOR_pilot
Ilyinskaya Hospital, JSC
Phase NA Enrolling by invitation
NCT06147154 2023-11-30
Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients
Qilu Hospital of Shandong University
Completed
NCT04575363 2023-11-09
PaCaBioMarkeR
CHU de Reims
Phase NA Recruiting
NCT02782182 2019-03-19
Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study
University of Chicago
Phase 1 Terminated